Literature DB >> 26155877

Design of pediatric oral formulations with a low proportion of methadone or phenobarbital for the treatment of neonatal abstinence syndrome.

Nora Provenza1, Ana C Calpena1, Mireia Mallandrich1, Blanca Pueyo1, Beatriz Clares2.   

Abstract

CONTEXT: Elaboration of oral liquid formulations is the best alternative when no marketed forms are available for pediatrics.
OBJECTIVE: The development, characterization and stability evaluation of methadone (MI, MII, MIII) and phenobarbital (PI, PII) can be used for the treatment of neonatal abstinence syndrome (NAS).
MATERIAL AND METHODS: A standard operating procedure was established and parameters such as appearance, pH, rheological behavior and drug content were evaluated at three temperatures for 90 days. RESULTS AND DISCUSSION: Changes in color of phenobarbital made necessary the storage below 25 °C. pH did not change in methadone solutions and was able to maintain phenobarbital solubilized. Degradation data at 4 °C fitted to Plateau equation followed by one phase decay. MI was stable for 60 days at the three temperatures; MII for 90 days at 4 and 25 °C and 60 days at 40 °C; MIII for 60 days at 4 °C, 15 days at 25 °C and 7 days at 4 °C. PI was stable for 60 days at 4 °C and 30 days at 25 °C. PII was stable for 7 days at 4 and 25 °C. All solutions met microbial specifications.
CONCLUSION: A correct dosage for the treatment of NAS was guaranteed.

Entities:  

Keywords:  Methadone; neonatal abstinence syndrome; pediatric formulations; phenobarbital

Mesh:

Substances:

Year:  2015        PMID: 26155877     DOI: 10.3109/10837450.2015.1055765

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  2 in total

1.  Development and validation of a HPLC-UV method for methadone hydrochloride quantification in a new oral solution with preservatives to be implemented in physicochemical stability studies.

Authors:  Elena Alba Álvaro-Alonso; Mª Paz Lorenzo; Ismael Escobar-Rodríguez; Antonio Aguilar-Ros
Journal:  BMC Chem       Date:  2022-05-14

2.  Physicochemical and Microbiological Stability of Two Oral Solutions of Methadone Hydrochloride 10 mg/mL.

Authors:  Elena Alba Álvaro-Alonso; Ma Paz Lorenzo; Andrea Gonzalez-Prieto; Elsa Izquierdo-García; Ismael Escobar-Rodríguez; Antonio Aguilar-Ros
Journal:  Molecules       Date:  2022-04-28       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.